Dihexa 10 mg capsules
The angiotensin-derived small molecule at ten milligrams per capsule, engineered stable enough for the oral route, and labelled as the non-peptide it is.
- ISO-certified laboratory
- COA per batch, ≥99% HPLC
- Discreet dispatch within 24 h
- Research use only
Built to survive the route
Dihexa descends from angiotensin IV but left peptide chemistry behind: the modifications that made it metabolically stable are exactly what qualify it for a capsule shelf that excludes true peptides. Its research interest, HGF/c-Met signalling and synaptic connectivity in animal models, comes almost entirely from one research group, as our compound page states and the dihexa record on PubMed confirms.
Ten milligrams per capsule suits the small-molecule dosing scale of that animal literature. Human evidence is absent; the cognition-shelf framing on the compound page keeps that boundary bright.
| Compound | Dihexa |
| Content | 10 mg per capsule |
| Class | Small molecule, peptide-derived |
| Proposed target | HGF / c-Met |
| Purity | ≥ 99% (HPLC) |
| Evidence base | Animal work, largely one group |
| Category | Research use only |
Oral viability here is engineered, not assumed, the compound page explains the difference.
Before the Dihexa 10 mg capsules reaches the bench
Capsule simplicity: dry, dark, sealed, done.
Engineered to outlast digestion
Why a small molecule with peptide ancestry earns the oral shelf that true peptides cannot.
The capsule shelf admits two kinds of survivor, and dihexa is the rarer one. Where the fragment products endure the stomach by being unusually acid-stable peptides, dihexa endures it by having stopped being a peptide at all, the modifications on its angiotensin-IV parent traded away the bonds an enzyme would cleave for a small-molecule frame digestion largely ignores. Oral viability here is engineered into the chemistry, not gambled on, which is the one qualification the capsule shelf tests for.
Researchers who buy dihexa capsules are handling ten milligrams per capsule of a compound whose interest, HGF and c-Met signalling, synaptic connectivity, comes almost entirely from a single research group’s animal work. Human evidence is absent, and the label states that rather than implying otherwise. The ten-milligram unit suits the small-molecule dosing scale of that literature, but scale is not endorsement: the figure reflects how the animal studies were built, not any claim about people.
Per capsule, per certificate
What the jar has to prove about ten uniform milligrams, and why thin replication raises the bar.
A capsule’s convenience hides its one hard question: does each unit truly hold the stated ten milligrams? Fill uniformity is a property of the run, not the recipe, so the evidence has to be the batch document for the exact lot that filled your jar, per-capsule content and the HPLC purity trace tied to that run. With dihexa the stakes are sharper, because a compound already thin on independent replication cannot also afford doubt about what sits inside the shell going into an assay.
Reconcile the lot on the jar against the certificate before anything else, since an unmatched number quietly detaches every reading from its paperwork. For a small molecule the identity line matters as much as purity: a found mass agreeing with dihexa’s predicted mass is what separates the real compound from the potent-sounding substitutes that circulate around it. Ten milligrams, one lot, a matching mass and a purity figure at or above 99 percent, documented that way, the jar can carry a result.
The cognition shelf
The peptide half of the cognition conversation, and the other capsule product.
The science behind Dihexa
Chemistry, evidence and honest limits.
Questions about the Dihexa 10 mg capsules
For the capsule shelf’s small molecule.